On December 16, 2024, the U.S. Food and Drug Administration (FDA) announced a nationwide recall affecting 136,181 bottles of ...
Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...
in adults. Miqnaf is an ultra-short course, once-a-day, three-day treatment for CABP, including those caused by multi-drug resistant (MDR) pathogens. The approval follows a favourable ...
(Getty Images) (NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step ...
These guidelines have set the foundation for conducting E&L studies, especially for high-risk dosage forms, and are complemented by the forthcoming ICH Q3E, which aims to standardize E&L ...